Pain Management

Product Code GIA00206
Publication Date March 2008
Publisher Global Industry Analysts
Product Type Report
Pages 297
Buy this product or for assistance call +44 20 7060 7474

This report analyzes the worldwide markets for Pain Management in Millions of US$. The specific product segments analyzed are Pain Management Pharmaceuticals, Pain Management Devices, and Pain Management Services. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2001 through 2010. A ten-year historic analysis is also provided for these markets with annual market analytics. The report profiles 131 companies including many key and niche players worldwide such as AstraZeneca PLC, Elan Corporation PLC, Eli Lilly and Company, Glaxo Smithkline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Organon International, Inc., Pfizer, Inc., Purdue Pharma, Sanofi Aventis, and Wyeth. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

  • I. Introduction, Methodology & Product Definitions
    • Study Reliability and Reporting Limitations
    • Disclaimers
    • Data Interpretation & Reporting Level
    • CAGR Disparities between Historic & Current Data
    • Quantitative Techniques & Analytics
    • Product Definitions and Scope of Study
    • Pain Management Pharmaceuticals
    • Pain Management Pharmaceuticals
    • Pain Management Services
  • II. Executive Summary
    • 1.Industry Overview
      • Pain Management Market to Witness Steady Growth
      • Factors Affecting Pain Management Industry
      • Challenges Faced
      • Trends and Issues
      • Generic Drugs Hogs Limelight...
      • Cox II Crisis Tarnishes Industry Growth
      • Novel Therapies to Propel Opioid and Non- Opioid Therapies
      • Neuropathic Pain - Still an Underserved Market
      • Cyclin-dependent kinase 5 (Cdk5)
      • Drug Dynamics in the Migraine Market
      • Pain Pathways - Gain a Second Look
      • Leading Players
      • Status of Major Pipeline Drugs for Pain Management: 2007
    • 2.Product Overview
      • Pain Management: An Overview
      • Managing Pain
      • What is Pain?
      • Assessment of Pain
      • Pain Management
      • Pain Management for Neonates
      • Pain Management in Kids
      • Pain Management in Older Adult Surgical Patients
      • Pain Therapeutics - An Introduction
      • Treatment of Pain
      • Pharmacologic Method
      • Non-pharmacological Method
      • Invasive Procedures
      • Palliative Care
      • Alternative Methods
      • Acupuncture
      • Biofeedback
      • Bioelectromagnetic Therapy
      • Biomagnetism and Magnetotherapy
      • Guided Imagery
      • Manual/Massage Therapies
      • Aromatherapy Massage
      • Swedish Massage
      • Deep Tissue Massage
      • Neuromuscular Therapy
      • Myofascial Release
      • Manual Lymph Drainage
      • Cranial Sacral Therapy
      • Reflexology
      • Naturopathy
      • Relaxation Therapy
      • Transcendental Meditation
      • Classification of Pain
      • Acute Pain
      • Postoperative pain
      • Labor pain
      • Visceral pain
      • Migraine
      • Treatment of Migraine
      • Chronic Pain
      • Cancer pain
      • Back Pain
      • Neuropathic Pain
      • Arthritic Pain
      • HIV-Related Pain
      • Diabetic Neuropathy
      • Osteo-and Rheumatoid Arthritis Pain
      • Pain Management Products and Services
      • Pain Management Pharmaceuticals
      • Nonprescription Drugs
      • Acetaminophen
      • Aspirin
      • Ibuprofen
      • Ketoprofen
      • Naproxen
      • Pramoxine
      • Counterirritants
      • Triethanolamine Salicylate (Trolamine)
      • Prescription Drugs
      • General Anesthetics
      • Local Anesthetics
      • Non-steroidal Anti-Inflammatories (NSAIDs)
      • Non-opioid Analgesics
      • Opioid Analgesics
      • Pain Management Devices
      • Electrical Spinal Cord Stimulators
      • Electrical Stimulus Devices
      • Transcutaneous Electric Nerve Stimulators (TENS)
      • Patient-Controlled Analgesia Infusion Devices
      • Pain Management Services
      • Home Care/Providence Home Health
      • Providence Hospices
      • Pain Management Centers and Clinics
      • Pain Rehabilitation Programs
    • 3.Regulatory Environment
      • An Overview of Pain Management Regulation
      • OTC Painkillers to Carry Conspicuous Safety Warnings
      • Federal Regulatory Norms of Controlled Substances
      • DEA Regulations
    • 4.Product Innovations/Introductions
      • Mallinckrodt Introduces Novel Pain Relieving Agent
      • Shionogi Unveils Cancer Pain Management Drug
      • NeuroTherm Launches RF Generators for Treatment of Heel Pain
      • McNeil Brings Chewable TYLENOL GoTabs Tablets
      • Barr Unveils Generic Version of ACTIQ
      • Orthofix Unveils e-PainCare
      • Organon Innovates Org 25969
      • Orthofix's BREG Division Launches Polar Care Motorized Cold Therapy System
      • Zynex Develops New Pain Management Device
      • Eli Lilly and Company Develops Cymbalta
      • Pfizer's Lyrica Gets Nod from the EC
      • New Pain Management Infusion Pumps from Sorenson
      • McKinley Unveils Accufuser Pain Management System
    • 5.Recent Industry Activity
      • Neuromed to Acquire US Rights for Oros Hydromorphone from Alza
      • China Aoxing to Acquire Chinese Pharmaceutical Company, Shijiazhuang Le Ren
      • Vyteris Holdings to Acquire Lehigh Valley Technologies
      • Younger America Pockets Life without Pain
      • PainCare Divests Center for Pain Management
      • Grand Slam Acquires IOMED
      • Ligand Accomplishes Divesture of AVINZA
      • CeNeS and Ergomed Collaborate for Phase II Trials of NMDA Antagonist CNS 5161
      • Sorenson Secures Approval to Market Ambulatory Infusion Pump in China
      • PainCare Pockets CPMASC
      • Moog Takes over Mckinley Medical Corp
      • PainCare Acquires REC, CareFirst Medical Associates
      • CLL Pharma Acquires Synt:em
      • AstraZeneca Partners with Pozen to Bring Novel Pain Management Therapy
      • Great Outdoors Acquires Somatic Systems Institute
      • PainCare Partners with Solstice Neurosciences to Offer Pain Management in CD
      • Elan Confers Eisai with European Rights of Prialt
      • Evotec Partners with Apeiron Biologics to Bring Novel Pain Therapy
      • Alpaca Enterprises Acquires Neuroscience Therapy Corp
      • PainCare Holdings Acquires Desert Pain Medicine Group.
      • Wex Pharma Inks Agreement with Boston Children's Hospital
      • Glenmark Inks Agreement with LVT to Market Pain Management Products
      • EKR Attains North American Marketing Rights for Gelclair
      • Grand Slam Acquires Cefar Medical
      • Omeros Acquires Nura
      • Hospira Inks Agreement with Premier
      • Pain Therapeutics Enters into Alliance with King Pharmaceuticals
      • Corgentech Merges with AlgoRx
      • Elder Pharmaceuticals Ventures into the Indian Pain Management Market
      • Xanodyne Acquires Pharmaceutical Assets of aaiPharma
      • Pro-Dex Acquires Dental Technology from IntraVantage
      • Encore Medical Acquires Compex Technologies
      • Sosei Acquires Arakis
      • Corgentech Signs Definitive Merger Agreement with AlgoRx
      • Elder Pharmaceuticals Enters into Marketing Agreement with TRB Chemedica
      • University Pain Management Center Signs Agreement with Somnia
      • Entelos and Organon to Extend Rheumatoid Arthritis (RA) Collaboration
      • NovaMed Establishes a New Pain Management Center at Indiana
      • Organon and Uriach Collaborate on Developing Kinase Inhibitors
      • Toray and Nippon to Co-Develop THCR...
      • AAIPharma Acquires Pain Products...
      • PainCare & Spine & Pain Center in a Definitive Merger Agreement...
      • Elan and Ingenium in a Strategic Alliance...
    • 6.Focus on Select Key Players
      • AstraZeneca PLC (UK)
      • Eli Lilly and Company (USA)
      • Glaxo Smithkline Plc (UK)
      • Johnson & Johnson (USA)
      • Merck & Co., Inc (USA)
      • Novartis Pharmaceuticals Corporation (USA)
      • Pfizer Inc. (USA)
      • Purdue Pharma (USA)
      • Sanofi Aventis (France)
      • Wyeth (USA)
    • 7.Global Market Perspective
  • III. Market
    • 1.The United States
      • A. Market Analysis
        • Current & Future Analysis
        • Pain Statistics in the US
        • Industry Overview
        • Measures to Thwart Drug Abuse
        • Market for Cancer Pain Therapeutics
        • Leading Players/Brands
        • Product Launches
        • Strategic Corporate Developments
        • Key Players
        • Eli Lilly and Company
        • Johnson & Johnson
        • Merck & Co., Inc.
        • Novartis Pharmaceuticals Corporation
        • Pfizer, Inc.
        • Purdue Pharma
        • Wyeth
      • B. Market Analytics
    • 2.Canada
      • Market Analysis
    • 3.Japan
      • A. Market Analysis
        • Current & Future Analysis
        • Strategic Corporate Developments
      • B. Market Analytics
    • 4.Europe
      • A. Market Analysis
        • Current & Future Analysis
        • Strategic Corporate Developments
      • B. Market Analytics
    • 4a.France
      • A. Market Analysis
        • Strategic Corporate Developments
        • Key Player Review
        • Sanofi Aventis
      • B. Market Analytics
    • 4b.Germany
      • Market Analysis
    • 4c.United Kingdom
      • A. Market Analysis
        • UK Pain Statistics
        • Key Player Review
        • Glaxo Smithkline Plc
        • AstraZeneca Plc
      • B. Market Analytics
    • 4d.Italy
      • Market Analysis
    • 4e.Spain
      • Market Analysis
    • 4f.Russia
      • Market Analysis
    • 4g.Rest of Europe
      • A. Market Analysis
        • Strategic Corporate Development
      • B. Market Analytics
    • 5.Asia-Pacific
      • A. Market Analysis
        • Current & Future Analysis
        • India
        • Strategic Corporate Developments
      • B. Market Analytics
    • 6.Latin America
      • Market Analysis
    • 7.Rest of World
      • Market Analysis
  • IV. Competitive Landscape
  • List of Tables
    • Table 1: Leading Players in the Global Pain Management Pharmaceuticals Market (2006): Market Share by Sales for Pfizer, Johnson & Johnson, Novartis, GlaxoSmithkline, and Others (includes corresponding Graph/Chart)
    • Table 2: World Recent past, Current & Future Analysis for Pain Management by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 3: World* Recent past, Current & Future Analysis for Pain Management by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 4: World Historic Review for Pain Management by Geographic Region - US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 5: World 20-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Dollar Revenue for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)
    • Table 6: World Recent past, Current & Future Analysis for Pain Management Pharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 7: World* Recent past, Current & Future Analysis for Pain Management Pharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 8: World Historic Review for Pain Management Pharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 9: World 20-Year Perspective for Pain Management Pharmaceuticals by Geographic Region - Percentage Breakdown of Dollar Revenue for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)
    • Table 10: World Recent past, Current & Future Analysis for Pain Management Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 11: World* Recent past, Current & Future Analysis for Pain Management Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 12: World Historic Review for Pain Management Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 13: World 20-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Dollar Revenue for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)
    • Table 14: World Recent past, Current & Future Analysis for Pain Management Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 15: World Long-Term Projections for Pain Management Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 16: World Historic Review for Pain Management Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 17: World 20-Year Perspective for Pain Management Services by Geographic Region - Percentage Breakdown of Dollar Revenue for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)
    • Table 18: Leading Oral Pain Relievers in the US Market for Pain Management (2006) - Percentage Breakdown of Value Sales by Brand for Orajel, Anbesol, Baby Orajel, Colgate Peroxyl, Zilactin, Glyoxide, Hyland's, Dentek Temparin, Orajel Mouth Aid, and Others (includes corresponding Graph/Chart)
    • Table 19: Leading OTC Pain Relievers in the US Market for Pain Management (2006) - Percentage Breakdown of Value Sales by Brand for Advil, Tylenol, Aleve, Bayer, Tylenol PM, Motrin IB, Excedrin, Tylenol Arthritis, Excedrin Migraine, Private label, and Others (includes corresponding Graph/Chart)
    • Table 20: US Recent past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 21: US Long-Term Projections for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 22: US Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 23: US 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (Includes corresponding graphs/chart)
    • Table 24: Canadian Recent past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 25: Canadian Long-Term Projections for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 26: Canadian Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 27: Canadian 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)
    • Table 28: Japanese Recent past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 29: Japanese Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 30: Japanese Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 31: Japanese 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)
    • Table 32: European Recent past, Current & Future Analysis for Pain Management by Geographic Region - France, Germany, UK, Italy, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 33: European Long-Term Projections for Pain Management by Geographic Region - France, Germany, UK, Italy, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 34: European Recent past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 35: European Long-Term Projections s for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 36: European Historic Review for Pain Management by Geographic Region - France, Germany, UK, Italy, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 37: European Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 38: European 20-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Dollar Revenue for France, Germany, UK, Italy, Spain, Russia & Rest of Europe Markets for Years 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)
    • Table 39: European 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)
    • Table 40: French Recent past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 41: French Long-Term Projections for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 42: French Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 43: French 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)
    • Table 44: German Recent past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 45: German Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 46: German Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 47: German 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)
    • Table 48: UK Recent past, Current & Future Analysis for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 49: UK Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 50: UK Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 51: UK 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)
    • Table 52: Italian Recent past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 53: Italian Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 54: Italian Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 55: Italian 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)
    • Table 56: Spanish Recent past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 57: Spanish Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 58: Spanish Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 59: Spanish 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)
    • Table 60: Russian Recent past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 61: Russian Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 62: Russian Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 63: Russian 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)
    • Table 64: Rest of Europe Recent past, Current & Future Analysis for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 65: Rest of Europe Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 66: Rest of Europe Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 67: Rest of Europe 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)
    • Table 68: Asia-Pacific Recent past, Current & Future Analysis for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 69: Asia-Pacific Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 70: Asia-Pacific Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 71: Asia-Pacific 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)
    • Table 72: Latin America Recent past, Current & Future Analysis for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 73: Latin America Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 74: Latin America Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 75: Latin America 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)
    • Table 76: Rest of World Recent past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
    • Table 77: Rest of World Long-Term Projections s for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 78: Rest of World Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
    • Table 79: Rest of World 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

Click here to download the TOC

Delivery Details

PDF:Delivered by email usually within 24 to 48 UK business hours.

Actions

© 2010 | Report Buyer is a trading name for Piribo Ltd. Registered in England and Wales No. 05051530 | VAT Reg No. GB 839 4556 85

comodo ev ssl site
Internet shopping is safe
SecurityMetrics for PCI Compliance, QSA, IDS, Penetration Testing, Forensics, and Vulnerability Assessment